Sign in with Google. Opens in new tab
bullish

Suzhou Ribo Life Science (瑞博生物) Pre-IPO Quick View: Scarcity of SiRNA Player

188 Views02 May 2025 02:00
​Suzhou Ribo Life plans to raise $100 million through a Hong Kong listing, with CICC and Citi as deal sponsors. They are a leading company in siRNA research.
What is covered in the Full Insight:
  • Introduction to Suzhou Ribo Life Science
  • Company's Key Products and Clinical Progress
  • Partnerships and Collaborations
  • Financial Overview and Pre-IPO Investors
  • Initial Market Impressions and Considerations
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 6-minute read)
Discussions
(Paid Plans Only)
chart-bar
Price Chart(Sign Up to Access)
analytics-chart
  • Loading...
x